The France Journal: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The France Journal.

Press releases published on July 1, 2026

SVD Announces Online Auction of 40,000 Surplus Wine Barrels from Sonoma Winery Facility
K2 Foundation Unveils New Brand Identity and Global Impact Strategy Following K2 Group's Evolution
Secro Appoints Guy de Pourtalès As Chief Technology Officer
La Côte d’Ivoire franchit une étape historique en matière de financement climatique agricole
SENSOIRE Debuts Paris-Designed Mulberry Silk Sleep Collection
Aecooly lance Cold Air, un ventilateur brumisateur portable conçu pour les fortes chaleurs
Alcatel-Lucent nomme Moussa Zaghdoud au poste de EVP Infrastructures, Plateformes et Services et CTO
Hardware Wallet Market to Surge at 23.8% CAGR, Anticipated to Reach USD 5.48 Billion by 2035
Autonomous Mobile Robot Market Projected to Hit USD 5.54 Billion in 2026 and USD 18.30 Billion by 2035, CAGR 14.2%
Online Sports Betting Market to Surge at 12.10% CAGR, Anticipated to Reach USD 148.95 Billion by 2035
ALLIANCE DEVELOPPEMENT CAPITAL SIIC: Communiqué sur l'assemblée générale ordinaire du 30 juin 2026
Correction: Abivax Announces Pricing of Highly Oversubscribed and Upsized $800M (€702M) Public Offering of American Depositary Shares
Correction: Abivax annonce la fixation du prix de l’Offre au public largement sursouscrite de 800 M$ (702 M€) d’American Depositary Shares
Amoéba has received marketing authorization in France for its biofungicide AXPERA
Amoéba obtient l’autorisation de mise sur le marché en France pour son biofongicide AXPERA
Amoéba verkrijgt in Frankrijk een vergunning voor het in de handel brengen van zijn biofungicide AXPERA
Amoéba obtém autorização de colocação no mercado em França para o seu biofungicida AXPERA
Amoéba obtiene la autorización de comercialización en Francia para su biofungicida AXPERA
Amoéba ottiene l’autorizzazione all'immissione in commercio in Francia per il suo biofungicida AXPERA
Abivax announces trading resumption of its ordinary shares on Euronext Paris

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

The France Journal

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.